HSA
TMDX icon

Hussman Strategic Advisors’s Transmedics TMDX Stock Holding History

Hussman Strategic Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31,500
Closed -$3.13M – 319
2026
Q1 		$3.13M Buy
31,500
+16,800
+114% +$2.19M 0.68% 26
2025
Q4 		$1.79M Buy
+14,700
New +$1.84M 0.43% 109

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Hussman Strategic Advisors's TMDX Position: Q2 2026 in Review

Hussman Strategic Advisors sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 31,500 shares — an estimated $3.13M sold.

Hussman Strategic Advisors first reported a position in TMDX in Q4 2025 and held it in 2 quarters. The position peaked at $3.13M in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Hussman Strategic Advisors reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Hussman Strategic Advisors sold 31,500 Transmedics shares in Q2 2026, an estimated $3.13M.
  • Hussman Strategic Advisors first reported a position in Transmedics in Q4 2025 and held it in 2 quarters.
  • Hussman Strategic Advisors's Transmedics position peaked at $3.13M in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.